Swiss germ-cell cancer consensus recommendations.

Beyer, Jörg; Berthold, Dominik; Bode, Peter-Karl; Cathomas, Richard; Fankhauser, Christian D; Fischer, Stefanie; Gillessen, Silke; Gross, Tobias; Hermanns, Thomas; Honecker, Friedemann; Lorch, Anja; Omlin, Aurelius; Papachristofilou, Alexandros; Roth, Beat; Rothermundt, Christian; Seiler, Roland; Spahn, Martin; Stenner, Frank; Bührer, Emanuel (2021). Swiss germ-cell cancer consensus recommendations. Swiss medical weekly, 151(33-34) EMH Schweizerischer Ärzteverlag 10.4414/SMW.2021.w30023

[img]
Preview
Text
smw_151_w30023.pdf - Published Version
Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND).

Download (625kB) | Preview

Approximately 420 men are diagnosed with germ-cell cancer (GCC) in Switzerland each year. Recent international guidelines outline management issues, but many aspects remain controversial in an area of highly individualised treatments. Even more than in other tumour types, in GCC the challenge is to choose exactly the correct treatment for an individual patient. Overtreatment in patients likely to be cured must be avoided to reduce long-term toxicities. On the other hand, treatment intensification is required in patients presenting with adverse prognostic factors. Therefore, referral to expert centres or consultations with an expert for a second opinion is strongly recommended. In 2020, Swiss experts discussed their strategies in a consensus meeting during the virtual Swiss Oncology and Haematology Congress (SOHC) in order to harmonise their concepts and to suggest optimal strategies for the management of GCC patients in Switzerland. Votes on controversial issues were obtained and are presented in this review wherever applicable.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Urology
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology

UniBE Contributor:

Beyer, Jörg; Gillessen, Silke; Gross, Tobias; Omlin, Aurelius Gabriel; Seiler-Blarer, Roland and Bührer, Emanuel

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1424-7860

Publisher:

EMH Schweizerischer Ärzteverlag

Language:

English

Submitter:

Rebeka Gerber

Date Deposited:

24 Nov 2021 16:03

Last Modified:

24 Nov 2021 16:03

Publisher DOI:

10.4414/SMW.2021.w30023

PubMed ID:

34495606

BORIS DOI:

10.48350/160874

URI:

https://boris.unibe.ch/id/eprint/160874

Actions (login required)

Edit item Edit item
Provide Feedback